Capital International Investors
DPLO

Capital International Investors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Capital International Investors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,309,527
Closed -$16.2M – 423
2019
Q3 		$16.2M Hold
3,309,527
– – 0.01% 336
2019
Q2 		$20.2M Buy
3,309,527
+375,900
+13% +$2M 0.01% 330
2019
Q1 		$17M Sell
2,933,627
-3,097,700
-51% -$32M 0.01% 332
2018
Q4 		$81.2M Buy
6,031,327
+926,136
+18% +$15.6M 0.04% 221
2018
Q3 		$99.1M Buy
+5,105,191
New +$109M 0.05% 225

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital International Investors's DPLO Position: Q4 2019 in Review

Capital International Investors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 3,309,527 shares — an estimated $16.2M sold.

Capital International Investors first reported a position in DPLO in Q3 2018 and held it in 5 quarters. The position peaked at $99.1M in Q3 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Capital International Investors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Capital International Investors sold 3,309,527 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $16.2M.
  • Capital International Investors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 5 quarters.
  • Capital International Investors's DIPLOMAT PHARMACY, INC. position peaked at $99.1M in Q3 2018.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Capital International Investors's 13F filing for Q4 2019, filed 18 Feb 2020.